Management of the patient with sickle cell disease

Journal of Intravenous Nursing

Volumn 21, Issue 1, 1998, Pages 27-40

  Rausch, Marianne ^a   Pollard, Donna ^a  

^a Coram Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BUTORPHANOL; CODEINE; HYDROMORPHONE; HYDROXYUREA; IBUPROFEN; INDOMETACIN; KETOROLAC; MORPHINE; NAPROXEN; OXYCODONE; PARACETAMOL; PETHIDINE;

ARTERY OCCLUSION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; FLUID THERAPY; HEMOLYSIS; HOME CARE; HOSPITAL CARE; HUMAN; NURSE; PAIN; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT EDUCATION; REVIEW; SICKLE CELL ANEMIA; VEIN OCCLUSION;

ANEMIA, SICKLE CELL; CHILD; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; MASS SCREENING; NURSE CLINICIANS; PARENTS; PATIENT CARE PLANNING; PATIENT EDUCATION;

EID: 0031938911     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bunn HF. Sickle cell disease pathogenesis and new approaches to therapy. Anemia: Current Issues 1990;111:2-4.
2. Reid CD, Charache S, Lubin B, eds. Management and therapy of sickle cell disease. NIH Publication 95-2117.
3. Emburg SH, Hebbel RP, Mohandas N, Steinberg M, eds. Sickle cell disease: basic principles and clinical practice. Philadelphia: Lippincott-Raven; 1994.
4. Disease and trauma monographs for acute care, Emergindex System, Topic Sickle Cell Disease Printout 1974-1996. Micromedex, Inc. Volume 87.
5. Lane P. Sickle cell disease. Pediatr Clin North Am 1996;43:639-664.
6. Steingart S. Management of patients with sickle cell disease. Med Clin North Am 1992;76.
7. Vichinsky E, Styles L. Sickle cell disease: pulmonary complications. Hematol Oncol Clin North Am 1996;10:1275-87.
8. King KE, Ness P. Sickle cell disease: treating anemia. Hematol Oncol Clin North Am 1996;10:1305-17.
9. Kinney T, Ware R. Sickle cell disease: the adolescent with sickle cell anemia. Hematol Oncol Clin North Am 1996;10:1255-65.
10. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Oncol 1991;28:221-6.
11. Davies S. Blood transfusion in sickle cell disease. Curr Opinion Hematol 1996;3:485-91.
12. Wright L. Newborn screening: the miracle and the challenge. J Pediatr Nurs 1992;7:26-42.
13. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. Clinical practice guideline no. 6. AHCPR publication number 93-0562. Rockville, Maryland: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1993.
14. Strickland D, et al. Pitfalls in newborn hemoglobinopathy screening: failure to detect beta thalassemia. J Pediatr 1995;121:304-7.
15. Annual report, Sickle Cell Disease Association of America, Inc. (SCDAA). Culver City, California: SCDAA, 1994.
16. Day S, et al. A successful Education program for parents with newly diagnosed sickle cell disease. J Pediatr Nurs 1992;7:52-7.
17. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. Quick reference for clinicians guideline no. 6. AHCPR publication number 93-0563. Rockville, Maryland: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1993.
18. Health maintenance guidelines. Sickle cell disease/hemoglobinopathies. State of New Jersey, 1997.
19. Falletta JM, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127:685-90.